Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis
Yıl: 2019 Cilt: 27 Sayı: 4 Sayfa Aralığı: 200 - 203 Metin Dili: İngilizce DOI: 10.5336/caserep.2019-65786 İndeks Tarihi: 11-05-2020
Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis
Öz: Cryptococcus neoformans is an opportunistic fungal agent, which may cause infectiondepending on the state of immunity. The agent is especially prone to be localized in the centralnervous system. Fingolimod is an immunomodulatory drug that is used in the treatment of Multiple Sclerosis (MS). The use of this drug leads to a decrease in lymphocyte count and thus might result in the occurrence of the opportunistic infections like Cryptococcosis. In this article, we presenta MS patient that underwent fingolimod treatment and developed Cryptococcus meningoencephalitis.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Salkowski CA, Balish E. Role of natural killer cells in resistance to systemic cryptococcosis. J Leukoc Biol. 1991;50(2):151-9. [Crossref] [PubMed]
- 2. Huffnagle GB, Traynor TR, McDonald RA, Olszewski MA, Lindell DM, Herring AC, et al. Leukocyte recruitment during pulmonary Cryptococcus neoformans infection. Immunopharmacology. 2000;48(3):231-6. [Crossref]
- 3. Özgüneş N, Dinç E, Ağaç E, Aydın I, Cetmeli G, Konuksal C. [A case of cryptococcosis meningitis]. Klimik Derg. 1996;9(3):158-9.
- 4. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases Society of America. Clin Infect Dis. 2010;50(3):291-322. [Crossref] [PubMed] [PMC]
- 5. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004;427(6972):355-60. [Crossref] [PubMed]
- 6. Brinkmann V, Cyster JG, Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant. 2004;4(7): 1019-25. [Crossref] [PubMed]
- 7. Carpenter AF, Goodwin SJ, Bornstein PF, Larson AJ, Markus CK. Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: here come the opportunistic infections? Mult Scler. 2017;23(2):297-9. [Crossref] [PubMed]
- 8. Zonios DI, Falloon J, Huang CY, Chaitt D, Bennett JE. Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore). 2007;86(2):78-92. [Crossref] [PubMed]
- 9. Nath DS, Kandaswamy R, Gruessner R, Sutherland DE, Dunn DL, Humar A. Fungal infections in transplant recipients receiving alemtuzumab. Transplant Proc. 2005;37(2): 934-6. [Crossref] [PubMed]
- 10. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc. 2008;83(2):181-94. [Crossref] [PubMed]
- 11. Chong I, Wang KY, Lincoln CM. Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings. J Clin Imaging. 2019;54:53-6. [Crossref] [PubMed]
- 12. Ward MD, Jones DE, Goldman MD. Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis. Mult Scler Relat Disord. 2016;9:47-49. [Crossref] [PubMed]
- 13. Achtnichts L, Obreja O, Conen A, Fux CA, Nedelchev K. Cryptococcal meningoencephalitis in a patient with multiple sclerosis treated with fingolimod. JAMA Neurol. 2015;72(10):1203-5. [Crossref] [PubMed]
- 14. Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virusnegative patients. Int J Infect Dis. 2006;10(1): 72-8. [Crossref] [PubMed]
- 15. Lee YC, Wang JT, Sun HY, Chen YC. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect. 2011; 44(5):338-45. [Crossref] [PubMed]
- 16. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virusnegative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33(5):690-9. [Crossref] [PubMed]
| APA | Kuruoglu T, DEVECİ A, TANYEL E, TERZİ M (2019). Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. , 200 - 203. 10.5336/caserep.2019-65786 |
| Chicago | Kuruoglu Tuba,DEVECİ AYDIN,TANYEL Esra,TERZİ Murat Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. (2019): 200 - 203. 10.5336/caserep.2019-65786 |
| MLA | Kuruoglu Tuba,DEVECİ AYDIN,TANYEL Esra,TERZİ Murat Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. , 2019, ss.200 - 203. 10.5336/caserep.2019-65786 |
| AMA | Kuruoglu T,DEVECİ A,TANYEL E,TERZİ M Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. . 2019; 200 - 203. 10.5336/caserep.2019-65786 |
| Vancouver | Kuruoglu T,DEVECİ A,TANYEL E,TERZİ M Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. . 2019; 200 - 203. 10.5336/caserep.2019-65786 |
| IEEE | Kuruoglu T,DEVECİ A,TANYEL E,TERZİ M "Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis." , ss.200 - 203, 2019. 10.5336/caserep.2019-65786 |
| ISNAD | Kuruoglu, Tuba vd. "Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis". (2019), 200-203. https://doi.org/10.5336/caserep.2019-65786 |
| APA | Kuruoglu T, DEVECİ A, TANYEL E, TERZİ M (2019). Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. Türkiye Klinikleri Journal of Case Reports, 27(4), 200 - 203. 10.5336/caserep.2019-65786 |
| Chicago | Kuruoglu Tuba,DEVECİ AYDIN,TANYEL Esra,TERZİ Murat Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. Türkiye Klinikleri Journal of Case Reports 27, no.4 (2019): 200 - 203. 10.5336/caserep.2019-65786 |
| MLA | Kuruoglu Tuba,DEVECİ AYDIN,TANYEL Esra,TERZİ Murat Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. Türkiye Klinikleri Journal of Case Reports, vol.27, no.4, 2019, ss.200 - 203. 10.5336/caserep.2019-65786 |
| AMA | Kuruoglu T,DEVECİ A,TANYEL E,TERZİ M Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. Türkiye Klinikleri Journal of Case Reports. 2019; 27(4): 200 - 203. 10.5336/caserep.2019-65786 |
| Vancouver | Kuruoglu T,DEVECİ A,TANYEL E,TERZİ M Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis. Türkiye Klinikleri Journal of Case Reports. 2019; 27(4): 200 - 203. 10.5336/caserep.2019-65786 |
| IEEE | Kuruoglu T,DEVECİ A,TANYEL E,TERZİ M "Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis." Türkiye Klinikleri Journal of Case Reports, 27, ss.200 - 203, 2019. 10.5336/caserep.2019-65786 |
| ISNAD | Kuruoglu, Tuba vd. "Cryptococcal Meningoencephalitis Treated with Fingolimod in a Patient with Multiple Sclerosis". Türkiye Klinikleri Journal of Case Reports 27/4 (2019), 200-203. https://doi.org/10.5336/caserep.2019-65786 |
